NTHL1 and breast carcinoma: Sample PD31203a showed a mutational signature (signature 30) that strongly matched the base excision repair NTHL1 deficiency pattern (Figure S2E), previously only seen in a breast cancer (Nik-Zainal et al., 2016) and an osteosarcoma (Behjati et al., 2017).